Medication Overuse Headache


  • Stewart J. Tepper MD

    Corresponding author
    1. Cleveland Clinic, Headache Center, Cleveland, OH, USA
    • Address all correspondence to S.J. Tepper, Cleveland Clinic Headache Center, C21, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

    Search for more papers by this author

  • Disclosures: Grants/research support (no personal compensation, all paid to Cleveland Clinic, and not tied to salary): ATI (active), Boston Scientific (active), Electrocore (active), GSK (active), and OptiNose (active).
  • All personal compensation <$10,000 per company.
  • Consultant: Allergan (active), ATI (active), Impax (active), Merck (active), Nautilus (active), NuPathe (active), and Zogenix (active).
  • Speakers Bureau: Allergan (active), ATI (active), Impax (active), Merck (active), Nautilus (active), and Zogenix (active).
  • Advisors Board: Allergan (active), ATI (active), Merck (active), Nautilus (active), NuPathe (active), Pfizer (active), and Zogenix (active).
  • Stock options: ATI (active).
  • Royalties (all active and <$10,000/year): University of Mississippi Press, Peoples Publishing House of Peking, Springer.

No abstract is available for this article.